Filtros de búsqueda

Lista de obras de

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast ⬇️

artículo científico publicado el 2 de mayo de 2013

A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor–Positive Breast Cancer ⬇️

artículo científico publicado el 8 de septiembre de 2011

A new prognostic score for AIDS-related lymphomas in the rituximab-era

artículo científico publicado en 2014

A phase I trial of gemcitabine administered as a 96-h continuous intravenous infusion in patients with advanced carcinoma and lymphoma

artículo científico publicado en 2006

A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer

artículo científico publicado en 2008

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103) ⬇️

artículo científico publicado el 1 de mayo de 2012

A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial

artículo científico publicado en 2010

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

article

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.

artículo científico publicado en 2014

Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status

artículo científico publicado en 2006

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

artículo científico publicado en 2017

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans

artículo científico publicado en 2016

Chemotherapy in Patients with Anthracycline and Taxane-Pretreated Metastatic Breast Cancer: An Overview ⬇️

artículo científico publicado el 1 de marzo de 2013

Chronic thalidomide and chemoembolization for hepatocellular carcinoma

artículo científico publicado en 2014

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

scientific article published on 03 June 2019

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors

artículo científico publicado en 2013

Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study ⬇️

artículo científico publicado el 25 de octubre de 2011

E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer.

artículo científico publicado en 2018

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083.

artículo científico publicado en 2017

Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs

artículo científico publicado en 2015

Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controls

artículo científico publicado en 2013

Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein

artículo científico publicado en 2014

GRB7 is required for triple-negative breast cancer cell invasion and survival ⬇️

artículo científico publicado el 18 de octubre de 2011

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.

artículo científico publicado en 2015

Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure

artículo científico publicado en 2016

High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer

artículo científico publicado en 2013

How Do I Treat Inflammatory Breast Cancer? ⬇️

artículo científico publicado el 1 de marzo de 2013

Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer

artículo científico publicado en 2017

Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma

artículo científico publicado en 2009

Human immunodeficiency virus associated lymphoma

artículo científico publicado en 2003

Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034

artículo científico publicado en 2009

Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103

artículo científico publicado en 2017

Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancer

artículo científico publicado en 2014

Inhibiting Ras signaling in the therapy of breast cancer

artículo científico publicado en 2003

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

artículo científico publicado en 2010

Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials

artículo científico publicado en 2012

Joseph Sparano on gene expression assays for breast cancer

artículo científico publicado en 2011

Learning from big data: are we undertreating older women with high-risk breast cancer?

artículo científico publicado en 2016

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer

artículo científico publicado en 2015

Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials

artículo científico publicado en 2012

Metastatic carcinoma: an unusual cause of focal brain lesions in HIV infection.

artículo científico publicado en 2003

Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic disease ⬇️

artículo científico publicado el 17 de febrero de 2013

Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study

publication published on 26 October 2021

Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism.

artículo científico publicado en 2017

Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer ⬇️

artículo científico publicado el 27 de agosto de 2012

Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma ⬇️

artículo científico publicado el 18 de abril de 2012

Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493).

artículo científico publicado en 2002

Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma

artículo científico publicado en 2010

Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

scientific article published on 26 September 2013

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105

artículo científico publicado en 2015

Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach

artículo científico publicado en 2014

Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).

artículo científico publicado en 2004

Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma

artículo científico publicado en 2003

Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group trial E3198.

artículo científico publicado en 2010

Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer

artículo científico publicado en 2011

Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer

artículo científico publicado en 2010

Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer

artículo científico publicado en 2009

Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group

artículo científico publicado en 2014

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo ⬇️

artículo científico publicado el 27 de diciembre de 2011

Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial

artículo científico publicado en 2011

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

artículo científico publicado en 2020

Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma

artículo científico publicado en 2011

Predicting cancer therapy-induced cardiotoxicity: the role of troponins and other markers

artículo científico publicado en 2002

Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial

artículo científico publicado en 2013

Prognostic gene expression assays in breast cancer: are two better than one?

artículo científico publicado en 2018

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

artículo científico publicado en 2014

Progress in adjuvant chemotherapy for breast cancer: an overview

artículo científico publicado en 2015

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

artículo científico publicado en 2015

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial

artículo científico publicado en 2012

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer

artículo científico publicado en 2017

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial

artículo científico publicado en 2016

Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

artículo científico publicado en 2010

Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196

artículo científico publicado en 2004

Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy

artículo científico publicado en 2010

Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer ⬇️

artículo científico publicado el 20 de septiembre de 2011

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

artículo científico publicado en 2005

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

artículo científico publicado en 2009

Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075).

artículo científico publicado en 2018

Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas

article

Structure and cancer immunotherapy of the B7 family member B7x

artículo científico publicado en 2014

T cell coinhibition and immunotherapy in human breast cancer ⬇️

artículo científico publicado el 1 de octubre de 2012

TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer ⬇️

artículo científico publicado el 16 de junio de 2012

Tailoring Adjuvant Therapy for Breast Cancer in the Elderly: Room for Improvement

artículo científico publicado en 2016

Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients ⬇️

artículo científico publicado el 26 de julio de 2012

Taxanes: impact on breast cancer therapy

artículo científico publicado en 2014

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations

artículo científico publicado en 2019

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions

artículo científico publicado en 2019

Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer.

artículo científico publicado en 2014

Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer

scientific article published on 08 October 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda